Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.
about
RASSF tumor suppressor gene family: biological functions and regulationMeru couples planar cell polarity with apical-basal polarity during asymmetric cell divisionMethylation of ras association domain protein 10 (RASSF10) promoter negative association with the survival of gastric cancer.N-terminal RASSF family: RASSF7-RASSF10.Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomasRASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes.RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant markerThe RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer.RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinomaRas-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma.Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma.Identification of Pax3 and Zic1 targets in the developing neural crest.The Process and Regulatory Components of Inflammation in Brain Oncogenesis.Epigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma.DNA methylation profiles of long- and short-term glioblastoma survivorsLoss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy.The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer.Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.KIBRAgene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia
P2860
Q26866080-02396614-77EF-457C-A043-8D14839FC2E6Q33860435-CE1F6479-2D67-43CA-A65A-B97EE9198E51Q34704994-AD005564-A567-447B-B09A-A3A29ABD26CAQ34974976-FC38F79C-2B43-42F5-879E-DD090B201965Q35204836-0E562616-8413-47A6-B7ED-17FFB71540C0Q35551978-4CE872E1-CE3E-4B29-9F31-A4ED2D8BC742Q35651346-B771DA83-E58E-499B-834F-4FAECD22B696Q35786661-45B04785-6509-4228-A82B-BBFAD9B30F32Q36383883-18DF1424-AA9B-4FE5-A6A9-F19281050FC7Q36735366-F0E5A7F1-9FCA-402F-B50D-4747526B6353Q36782418-8CF2B812-B38F-4BDA-AD72-98A95627BE7AQ37096218-7EC6B0D6-51B4-4B20-9482-0173C9215C6DQ37420605-B4983E8C-69D0-4F48-8AD4-88838CDD6414Q37601791-BBFBAFDC-AEE2-4461-84CF-36A9F809A227Q39202332-17B71A07-4C71-45D6-A5ED-356C7D95BBA7Q39380271-6E943F9B-D87A-4C32-8D16-E452E8F0B135Q41386607-F68CF3BB-A9A9-4D4C-9271-E3C8A72C0B7BQ42184843-C741BCEF-F7A6-4571-8321-46BF008F9BB0Q42239802-A53A08B6-2188-47CD-AC79-6F1622148CF2Q43769413-200141BC-1D9A-46CE-A331-CFA63114EEE0Q58041990-7B8F9A53-0561-4C2E-82CB-8AEF85A1923D
P2860
Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Epigenetic inactivation of the ...... early event in gliomagenesis.
@en
Epigenetic inactivation of the ...... early event in gliomagenesis.
@nl
type
label
Epigenetic inactivation of the ...... early event in gliomagenesis.
@en
Epigenetic inactivation of the ...... early event in gliomagenesis.
@nl
prefLabel
Epigenetic inactivation of the ...... early event in gliomagenesis.
@en
Epigenetic inactivation of the ...... early event in gliomagenesis.
@nl
P2093
P2860
P356
P1433
P1476
Epigenetic inactivation of the ...... early event in gliomagenesis.
@en
P2093
A D Chalmers
C B Sangan
H R Summersgill
N Underhill-Day
P2860
P2888
P304
P356
10.1038/ONC.2010.471
P407
P577
2010-10-18T00:00:00Z